Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ABIONYX Pharma SA (GB:0RAG)
LSE:0RAG
Holding GB:0RAG?
Track your performance easily
0RAG Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.92 - €1.44
Previous Close€1.36
Volume0.00
Average Volume (3M)207.00
Market Cap
€45.73M
Enterprise Value€46.20M
Total Cash (Recent Filing)€4.03M
Total Debt (Recent Filing)€4.49M
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Mar 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares OutstandingN/A
10 Day Avg. Volume44
30 Day Avg. Volume207
Standard Deviation0.27
R-Squared0.00746
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)15.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0RAG FAQ
What was ABIONYX Pharma SA’s price range in the past 12 months?
ABIONYX Pharma SA lowest share price was €0.92 and its highest was €1.44 in the past 12 months.
What is ABIONYX Pharma SA’s market cap?
Currently, no data Available
When is ABIONYX Pharma SA’s upcoming earnings report date?
ABIONYX Pharma SA’s upcoming earnings report date is Mar 18, 2025 which is in 116 days.
How were ABIONYX Pharma SA’s earnings last quarter?
ABIONYX Pharma SA released its earnings results on Sep 26, 2024. The company reported -€0.065 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.065.
Is ABIONYX Pharma SA overvalued?
According to Wall Street analysts ABIONYX Pharma SA’s price is currently Overvalued.
Does ABIONYX Pharma SA pay dividends?
ABIONYX Pharma SA does not currently pay dividends.
What is ABIONYX Pharma SA’s EPS estimate?
ABIONYX Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABIONYX Pharma SA have?
ABIONYX Pharma SA has 34,931,010 shares outstanding.
What happened to ABIONYX Pharma SA’s price movement after its last earnings report?
ABIONYX Pharma SA reported an EPS of -€0.065 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ABIONYX Pharma SA?
Currently, no hedge funds are holding shares in GB:0RAG
---
ABIONYX Pharma SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.50%
12-Months-Change
Fundamentals
Return on Equity
-47.89%
Trailing 12-Months
Asset Growth
11.67%
Trailing 12-Months
Company Description
ABIONYX Pharma SA
ABIONYX Pharma SA is a biopharmaceutical company, which engages in discovery and development of novel therapies based on high-density lipoproteins and the metabolism of lipids for the treatment of associated cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Labege, France.
---
Technical Analysis
---